Editas Medicine, Inc.

Historical 13F Holders

Symbol
EDIT
CUSIP
28106W103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 28106W103 since 12/18/2024, largest first.

Filer % of Class Filed
Commodore Capital LP 13G
9.9% 6/2/2026
Event 5/26/2026
TCG Crossover GP III, LLC 13G
9.9% 6/3/2026
Event 5/27/2026
BlackRock, Inc. 13G 7.8% 10/27/2026
Event 9/30/2026
ADAR1 Capital Management, LLC 13G
5.8% 8/14/2026
Event 6/30/2026
RA Capital Management, L.P. 13G
5.8% 6/3/2026
Event 5/27/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Deep Track Capital, LP 13G/A
0% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 224 139 M $356M
2026 Q2 221 119 M $386M
2026 Q1 212 51.8 M $128M
2025 Q4 203 49.9 M $102M
2025 Q3 200 43.0 M $149M
2025 Q2 198 41.3 M $90.9M
2025 Q1 198 44.0 M $51.0M
2024 Q4 208 51.1 M $64.8M
2024 Q3 231 55.1 M $221M
2024 Q2 238 56.4 M $263M
2024 Q1 228 67.9 M $504M
2023 Q4 229 58.8 M $596M
2023 Q3 225 61.7 M $481M
2023 Q2 241 62.8 M $517M
2023 Q1 237 53.0 M $384M
2022 Q4 254 54.0 M $481M
2022 Q3 270 48.3 M $594M
2022 Q2 263 47.5 M $566M
2022 Q1 261 45.4 M $866M
2021 Q4 309 51.1 M $1.37B
2021 Q3 329 52.4 M $2.18B
2021 Q2 324 52.2 M $2.98B
2021 Q1 317 53.2 M $2.25B
2020 Q4 320 53.0 M $3.75B
2020 Q3 244 55.2 M $1.57B
2020 Q2 243 54.4 M $1.63B
2020 Q1 203 45.8 M $1.02B
2019 Q4 234 45.8 M $1.36B
2019 Q3 189 45.0 M $1.02B
2019 Q2 196 40.0 M $990M
2019 Q1 205 37.5 M $917M
2018 Q4 197 34.5 M $784M
2018 Q3 201 33.8 M $1.08B
2018 Q2 218 32.6 M $1.17B
2018 Q1 201 31.2 M $1.03B
2017 Q4 153 30.4 M $934M
2017 Q3 119 29.1 M $698M
2017 Q2 111 29.2 M $490M
2017 Q1 99 27.5 M $614M
2016 Q4 84 23.5 M $381M
2016 Q3 75 22.2 M $299M
2016 Q2 68 22.6 M $550M
2016 Q1 50 18.2 M $625M